← Back to Screener
GeneDx Holdings Corp. Warrant (WGSWW)
Price$0.01
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-99.71%
Price vs S&P 500 (4W)-3.22%
VGM Score68.77
All Metrics
Price vs S&P 500 (YTD)-94.30%
10-Day Avg Trading Volume0.10M
3-Month Avg Trading Volume0.08M
52-Week High$0.13
26-Week Price Return-91.78%
13-Week Price Return-40.00%
3-Month Return Std Dev460.97%
Year-to-Date Return-87.34%
5-Day Price Return-31.03%
Month-to-Date Return-47.37%
Price vs S&P 500 (13W)-48.25%
Beta4.45x
52-Week Low$0.00
mGradeB
vgmGradeB
Show chart for
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
WGSWWGeneDx Holdings Corp. Warrant | — | — | B | $0.01 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | B | C | $7.41 |
| PRVAPrivia Health Group, Inc. Common Stock | D | B | D | $21.63 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | $52.21 |
| PNTGThe Pennant Group, Inc. Common Stock | C | B | C | $31.71 |
| OMDAOmada Health, Inc. Common Stock | D | A | B | $17.93 |
| INNVInnovAge Holding Corp. Common Stock | D | C | C | $7.30 |
| USPHUS Physical Therapy Inc | C | C | D | $63.45 |
| TALKTalkspace, Inc. Common Stock | F | B | B | $5.22 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | C | A | B | $5.79 |
| ALPSALPS Group Inc Ordinary Share | — | — | F | $0.71 |
About
GeneDx Holdings is a genomics company providing diagnostic testing for rare and ultra-rare pediatric genetic disorders through exome and genome sequencing. The company is positioned to capitalize on the expected shift toward genetic testing as a standard diagnostic tool for genetic disease. Its services enable early diagnosis and precision medicine while generating valuable genomic data for clinical discovery and improved patient outcomes.